SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Description
Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the immune defects that predispose an individual to persistent
